Download presentation
Presentation is loading. Please wait.
Published byAde Agusalim Modified over 5 years ago
1
Information for Action HCAI Surveillance Data: Laboratory data 15th July 2015 Mari Morgan
WHAIP Surveillance
2
Laboratory Surveillance Schemes
Staphylococcus aureus bacteraemia Clostridium difficile WHAIP Surveillance
3
Source of Data Specimen data entered into Trak
DataStore extracts results from Trak Records that meet certain criteria are extracted from DataStore for use in surveillance Data is processed, denominators applied, used for report production WHAIP Surveillance
4
Criteria for Extraction from DataStore
S. aureus bacteraemia Specimen type = blood culture Organism identified = S. aureus MRSA & MSSA distinguished on basis of antimicrobial sensitivity pattern Specimen date (based on date received) is within date range of report WHAIP Surveillance
5
Criteria for Extraction from DataStore
C. difficile Test type = C. difficile GDH GDH result = positive Test type = C. difficile toxin test Toxin test result = positive Specimen date (based on date received) is within date range of report Age is > 2 years or unknown WHAIP Surveillance
6
Data Processing Deduplication
S. aureus bacteraemia – if < 14 days between consecutive positives, excluded as a duplicate episode C. difficile – if < 28 days between consecutive positives, excluded as a duplicate episode Surveillance definitions – clinically you may not treat this as a separate episode WHAIP Surveillance
7
Data Processing Samples from patients in private hospitals, privately run dialysis units and post-mortem samples excluded Samples assigned as inpatient / non-inpatient based on the type of ward and the type of patient Where inpatient/non-inpatient unknown, assumed to be inpatient until updated by HB Where age is unknown for C. difficile, assumed to be > 2 years until updated by HB In datastore field called wholoc – says whether ward is ip, op etc and the patcat – ip or op but patcat not used in very standardised way, often used to distinguish private from nhs WHAIP Surveillance
8
Denominators Monthly admissions data by HB and hospital provided by NHS Wales Informatics Service (NWIS) – where up to date data unavailable, data from the equivalent month in the previous year is used Mid year population estimates from Office for National Statistics (ONS) – 2014 data published at end of June (a proportion of the population is used for calculating monthly rates) If we didn’t use a proportion of the population, then we would be using the same denom throughout but the numerator would keep increasing. Rates would look really good at the beginning of the year - lull into false sense of security WHAIP Surveillance
9
Reports Monthly Dashboard
C. difficile, MRSA bacteraemia and MSSA bacteraemia Released on or before 7th of month Monthly update tab – data for current and previous financial years – numbers, rates per 1000 admissions and rates per 100,000 population Target reduction tab – progress against current Tier 1 target, Apr 14 – Sep 15 WHAIP Surveillance
10
WHAIP Surveillance
11
WHAIP Surveillance
12
Reports 6 monthly reports
C. difficile, MRSA bacteraemia and MSSA bacteraemia Released in November for Apr – Sep data Released in May for previous financial year – numerator data for FY does not change after that report published Rates may change slightly one new mid year pop estimates become available WHAIP Surveillance
13
WHAIP Surveillance
14
WHAIP Surveillance
15
Reports Maps A package of sample C. difficile maps was sent out in March and prescribing maps in April for data to end Sep 14 plus an evaluation form Additional data on the location of residence of patient and the GP of the patient are used to produce these maps All prescribing maps and the most popular C. difficile maps (Wales and HB) will be sent out by the end of July for the 2014/15 FY data WHAIP Surveillance
16
Clostridium difficile surveillance
Maps by HB of diagnosis WHAIP Surveillance Update
17
Clostridium difficile surveillance
Maps by HB of residence WHAIP Surveillance Update
18
Clostridium difficile surveillance
Maps by GP of patient Our most popular map WHAIP Surveillance Update
19
Clostridium difficile surveillance
2014/15 FY report has been issued – 16% reduction in numbers, but variable across HBs Wales rate = 43/100,000 population (51 in 2013/14) Target = 31/100,000 population WHAIP Surveillance Update
20
Future Reports Conversion of current monthly dashboard to Tableau
Development of early warning system in Tableau – weekly unprocessed data to identify unusually high numbers WHAIP Surveillance
21
WHAIP Surveillance
22
Thank you to all the healthcare organisations in Wales for their help with these surveillance schemes. WHAIP Surveillance
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.